Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)

Francisco Airton Castro Rocha, Atul Deodhar

Research output: Contribution to journalComment/debatepeer-review

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s10067-021-05741-4.

Original languageEnglish (US)
Pages (from-to)3025
Number of pages1
JournalClinical Rheumatology
Volume40
Issue number7
DOIs
StatePublished - Jul 2021
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)'. Together they form a unique fingerprint.

Cite this